Viewing StudyNCT00250211



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00250211
Status: COMPLETED
Last Update Posted: 2016-02-24
First Post: 2005-11-04

Brief Title: Magnetic Resonance Spectroscopic Imaging MRS and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
Sponsor: AHS Cancer Control Alberta
Organization: AHS Cancer Control Alberta

Organization Data

Organization: AHS Cancer Control Alberta
Class: OTHER
Study ID: CNS-09-0027 ethics 21780
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: AHS Cancer Control Alberta
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Cross Cancer Institute OTHER